Publications Digest

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Value-based Publications Digest. In a recent publication, Vogler et al. proposed fit-for-purpose policy recommendations based on the analysis of current funding and pricing structures for point-of-care tests (POCTs) for community-acquired acute respiratory tract infections across Europe. The authors aimed to improve antibiotic prescribing for respiratory infections by enhancing the uptake of POCTs. The study suggested several funding policy and pricing-related recommendations ‒ such as physician-focused remuneration models, public reimbursement coverage, and strategic procurement approaches ‒ which can substantially boost the implementation of rapid diagnostic tools in outpatient settings.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Sustainability Publications Digest. In a recent publication, Haluza et al. conducted an exploratory survey at the General Hospital in Vienna, Austria, to assess anesthesia team members’ perspectives on precycling and recycling of anesthetic gases. The study revealed a generally positive attitude toward adopting sustainable practices, suggesting a strong potential for reducing volatile anesthetic use through active staff engagement.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Cocco et al. applied early economic modeling to establish target product profile specifications based on cost-effectiveness considerations, helping developers define key test performance criteria. The authors used the example of a novel rapid diagnostic for Clostridioides difficile infection in the UK setting. The study underscores how well-defined target product profiles can guide diagnostic test development to address pressing clinical needs.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Buccheri et al. explored the challenges of conducting randomized controlled trials (RCTs) for high-risk medical devices, emphasizing the added complexities of intervention costs, patient randomization, and blinding processes. Drawing on experience from the CORE-MD project and large-scale pharmaceutical trials during the COVID-19 pandemic, the authors highlighted the potential of large simple RCTs for high-risk medical devices. These trials leverage routine healthcare data to improve efficiency, reduce costs, and accelerate patient recruitment while maintaining robust clinical evidence.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Value-based Publications Digest. In a recent publication, Messori et al. analyzed an algorithm for identifying innovative, high-risk medical devices in Tuscany, Italy. Due to its limitations ‒ such as a narrow selection of qualifying devices and reliance on strict objective criteria ‒ the authors introduced a "potentially innovative" category to accommodate devices with clinical and economic value. Based on an analysis of 17 devices, this refined classification supports a structured procurement approach, with plans for regional implementation in hospitals in the coming months.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Sustainability Publications Digest. In a recent publication, Morris et al. conducted a scoping review of data on waste and greenhouse gas emissions in ophthalmic surgery. Results of 10 studies revealed that most emissions are linked to the procurement of surgical materials, followed by travel emissions and building energy. The authors also proposed a standardized waste-lifecycle framework to organize future research to help generate robust evidence for implementing impactful waste reduction strategies in ophthalmology.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Tornvall et al. conducted a systematic review of 12 economic evaluations of mHealth interventions for type 2 diabetes management. Most solutions ‒ featuring smartphone applications with text messaging and connected medical devices ‒ were generally deemed cost-effective or cost-saving. However, the authors highlighted moderate reporting quality, with a median CHEERS score of 59%. Methodological heterogeneity in outcome reporting further limits the overall robustness and comparability of the evidence for decision-makers.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Valls-Esteve et al. explored the integration and evolution of 3D printing and additive manufacturing (3DP/AM) in Spanish hospitals. The authors conducted a qualitative survey and collected data in two phases before and after the COVID-19 pandemic. Their findings revealed an increased adoption of well-defined in-house 3DP/AM systems for custom surgical applications, with notable progress in fields like traumatology and maxillofacial surgery. Limited human resources, financial constraints, and regulatory compliance were critical challenges in introducing 3D/AM in hospitals.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Value-Based Procurement Publications Digest. In a recent publication, Vogler et al. examined global pull incentives within public health policies aimed at promoting the market entry of novel antibiotics and diagnostics. Their analysis identified a range of pricing and reimbursement initiatives and offered a review of procurement incentives ‒ including value-based procurement, pooled procurement, and subscription-based models that decouple prices from volumes.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Fanshawe et al. systematically reviewed statistical methods for analyzing the performance of sequential diagnostic testing. The authors addressed five key themes: methods for combining tests, estimation of conditional dependence, repeated testing for risk assessment, adjustment for an imperfect reference standard, and meta-analysis of test sequences. This review offers methodological insights that enhance the precision and reliability of diagnostic evaluations.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Ataiy et al. surveyed 10 digital health application manufacturers to identify key barriers in Germany’s fast-track approval process. Challenges included conducting clinical trials to demonstrate clinical effects, negotiating pricing, and improving market acceptance. The authors emphasized that closer collaboration among stakeholders is essential to streamline approval processes while ensuring patient safety and accessibility.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Furman et al. conducted a qualitative analysis of hospital-based health technology assessment (HB-HTA) implementation in Poland to address the growing need for evidence-based evaluation of healthcare investments. The study found that while HB-HTA enhances decision-making capabilities and strengthens staff expertise, its adoption remains limited due to insufficient organizational and financial incentives.